# Notice of Intent to Sole Source: Vaccine Adverse Event Reporting System (VAERS) & Safety Monitoring Support

Canonical: https://abierto.us/opportunities/cber2026133723

- Solicitation number: CBER-2026-133723
- Notice type: Special notice
- Status: Closed. Deadline was September 18, 2026 at 3:30 PM EDT
- Department: Department of Health and Human Services
- Agency: Food and Drug Administration
- Contracting office: FDA Office of Acq Grant SVCS (75F401)
- NAICS: 541720 Research and Development in the Social Sciences and Humanities
- Product or service code: AJ11 General Science And Technology R&D Services; General Science And Technology; Basic Research
- Set-aside: 8(a) set-aside
- Place of performance: Carmel, California
- First posted: September 10, 2026
- Last posted: September 10, 2026
- SAM.gov: https://sam.gov/workspace/contract/opp/074c7f0416bf4356ba526140dc9488e9/view

## Description

The Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER)’s Office of Biostatistics and Pharmacovigilance (OPBV)’s Division of Pharmacovigilance (DPV) is responsible for monitoring the safety of vaccines and biologics once they are approved for use under a Biologic Licensing Application (BLA) or authorized for use under an Emergency Use Authorization (EUA). The Contractor shall furnish the necessary services and qualified personnel needed to perform the Statement of Work.

## Publications

- September 10, 2026: Special notice, due September 18, 2026 at 3:30 PM EDT. Notice 074c7f0416bf4356ba526140dc9488e9. https://sam.gov/workspace/contract/opp/074c7f0416bf4356ba526140dc9488e9/view

## Points of contact

- Rodney D. Aytch, rodney.aytch@fda.hhs.gov, 2404027515

---
Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/cber2026133723.